Press Release

VIS Reaffirms Entity Rating of OBS Pharma (Private) Limited

Karachi, December 17, 2025: VIS Credit Rating Company Limited (VIS) has reaffirmed the entity ratings of OBS Pharma (Private) Limited (‘OBS Pharma’ or the ‘Company’) at ‘A/A1’ (‘Single A/A One’). Medium to long term rating of ‘A’ indicates good credit quality; protection factors are adequate. Risk factors may vary with possible changes in the economy. Short term rating of ‘A1’ indicates strong likelihood of timely repayment of short-term obligations with excellent liquidity factors. Outlook on the assigned ratings is ‘Stable’. Previous rating action was announced on September 23, 2024.

The ratings reflect OBS Pharma Group’s strong market position in Pakistan’s pharmaceutical sector. They also incorporate the sector’s Medium-to-Low business risk profile, supported by stable demand and low cyclicality, although regulatory uncertainty and volatility in imported input costs remain notable challenges. The Company’s portfolio is concentrated in women’s healthcare and dermatology; however, the established market positions of key brands within their respective therapeutic segments help mitigate concentration risk. Gross margins normalized in CY24 with the commencement of in-house manufacturing, and further improvement was recorded in 1HCY25 driven by operational efficiencies and lower finance costs. Profitability is expected to strengthen gradually amid more stable raw material prices and easing cost pressures.

The Company’s capital structure remains weighted toward long-term financing. Equity continued to build through profit retention, contributing to a steady improvement in gearing and leverage indicators. Liquidity remains adequate; although higher finance costs constrained debt-servicing capacity in CY24. Post-acquisition integration and operational synergies have strengthened cash flows, supporting both liquidity and coverage. Looking ahead, sustained profitability, maintenance of manageable leverage, and continued effectiveness of liquidity management will remain important.


For further information on this ratings announcement, please contact at 021-35311861-64 or email at info@vis.com.pk.

Applicable Rating Criteria: Corporates:
https://docs.vis.com.pk/docs/CorporateMethodology.pdf

VIS Issue/Issuer Rating Scale
https://docs.vis.com.pk/docs/VISRatingScales.pdf

Information herein was obtained from sources believed to be accurate and reliable; however, VIS Credit Rating Company Limited (VIS) does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. VIS, the analysts involved in the rating process and members of its rating committee do not have any conflict of interest relating to the rating(s)/ranking(s) mentioned in this report. VIS is paid a fee for most rating assignments. This rating/ranking is an opinion and is not a recommendation to buy or sell any securities. Copyright December 17, 2025 VIS Credit Rating Company Limited. All rights reserved. Contents may be used by news media with credit to VIS.